Familial early puberty: presentation and inheritance pattern in 139 families by unknown
Durand et al. BMC Endocrine Disorders  (2016) 16:50 
DOI 10.1186/s12902-016-0130-xRESEARCH ARTICLE Open AccessFamilial early puberty: presentation and
inheritance pattern in 139 families
Adélaïde Durand1, Anu Bashamboo2, Ken McElreavey2 and Raja Brauner1*Abstract
Background: The mechanism that initiates the onset of puberty is largely unknown but the age of onset is mainly
under genetic control and influenced by environmental factors including nutrition. The coexistence in the same
family of central precocious puberty and advanced puberty, both representing early puberty, suggests that they
may represent a clinical spectrum of the same trait due to early activation of the GnRH pulse generator. We
therefore evaluated the mode of inheritance of early puberty in a large series of familial cases.
Methods: A retrospective, single center study was carried out on 154 probands (116 girls and 38 boys), from 139
families seen for idiopathic central precocious puberty (onset before 8 years in girls and 9–10 years in boys, n = 93)
and/or advanced puberty (onset between 8 and 10 years in girls and 10 and 11 years in boys, n = 61) seen over a
period of 8 years.
Results: Of the 139 families, 111 (80.4 %) had at least one affected 1st degree relatives, 17 (12 %) had only 2nd, 5
(3.6 %) only 3rd and 3 (2.2 %) had both 2nd and 3rd degree affected individuals. In the two remaining families, the
unaffected mother had affected girls from two unaffected fathers. In the majority of families the inheritance of the
phenotype was consistent with autosomal dominant mode of transmission with incomplete penetrance. An
exclusively maternal mode of transmission could be observed or inferred in 83 families, paternal in only 2 families
(p < 0.0001) and both maternal and paternal modes in 15 families.
In the 139 families, 374 cases of early puberty were identified of whom 315 (84.2 %) were affected females and
59 (15.8 %) affected males (p < 0.0001). Twenty one percent of families had exclusively precocious puberty, 25 %
had exclusively advanced puberty and 54 % had combinations of both.
Conclusions: The data confirm the high incidence of affected girls with familial early puberty. The mode of
inheritance of the phenotype is predominantly maternal. More than half of the families included both precocious
and advanced puberty suggesting similar genetic factors.
Keywords: Advanced puberty, Autosomal inheritance, Bilineal inheritance, Central precocious puberty, Early puberty,
Familial puberty, GnRH, Hypothalamic-pituitary-gonadal axis, Precocious puberty, Unilineal inheritanceBackground
Central precocious puberty (PP) is defined as the devel-
opment of sexual characteristics before the age of 8 years
in girls and 9–10 years in boys and this is due to the pre-
mature activation of the hypothalamo-pituitary-gonadal
axis [1]. Girls are affected more frequently than boys, and
in girls the PP is usually idiopathic. Advanced puberty
(AP) is defined as the onset of puberty in girls at 8–10
years and in boys at 10–11 years.* Correspondence: raja.brauner@wanadoo.fr
1Fondation Ophtalmologique Adolphe de Rothschild and Université Paris
Descartes, Paris, France
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeThe mechanism that initiates the onset of puberty is
largely unknown but the age of onset is mainly under
genetic control and influenced by environmental factors
including nutrition [2, 3]. Although obesity can contrib-
ute to early puberty, genetic factors are the strongest
predictors of early puberty in different world populations
[4–6]. Evidence to support a genetic cause of PP is sug-
gested by familial clustering with up to 27.5 % of central
PP cases are familial [7]. The percentage of familial cases
may actually be higher because some patients defined as
sporadic may have had family members with AP/PP in
previous generations and furthermore patients with APle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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sent a clinical spectrum of the same trait due to early
activation of the GnRH pulse generator [7].
Understanding the causes of PP is important since it is
reported to be linked with increased risk of other dis-
eases including polycystic ovaries, metabolic diseases
and cancer [8, 9]. In addition, the cause of early puberty
may possibly determine the evolution of the condition
and also help with the therapeutic indications [10].
Known genetic causes of PP are rare. Although muta-
tions involving kisspeptin and its receptor and more re-
cently MKRN3 are associated with PP, other rare genetic
variants in genes implicated in the regulatory mechan-
ism of GnRH secretion such as TAC3, TACR3, LIN28B,
GABRA1 and NPY are difficult to link with PP since
unaffected family members can carry the variant or
functional studies fail to show altered biological activity
of the mutant proteins [11–13].
Here, we describe a series of 154 probands from
139 families seen consecutively by the same senior
pediatric endocrinologist for PP or AP. Our data con-
firm previous observations of an increased frequency
of affected girls compared with boys and furthermore




This retrospective single-center cohort study was carried
out on 154 probands (116 girls and 38 boys) from 139
families, seen for early puberty (93 PP and 61 AP) with a
familial component by a senior pediatric endocrinologist
(R Brauner) in a university pediatric hospital from April
2004 to April 2012 (over 8 years). All familial forms
evaluated in this period were included. In girls, central
PP was diagnosed by breast development before the age
of 8 years accompanied by the presence of pubic or axil-
lary hair, a growth rate greater than 2 standard deviation
score (SDS) the year before clinical evaluation and/or a
bone age (BA) more than 2 years above the chrono-
logical age [14]. In boys, PP was diagnosed by pubic hair
development associated with testicular enlargement (tes-
ticular volume index i.e. length × width > 4 cm2) before
9–10 years [15]. We choose this definition as testicular
enlargement is not as obvious as the other signs of
puberty. AP was diagnosed by the appearance of these
clinical signs in girls between the ages of 8 and 10 years
and in boys between the ages of 10 and 11 years.
Transmission
Familial history of early puberty was defined as the age
mothers undergoing menarche (data available for all
probands with the exception of 3 cases of PP and 2 of
AP) before the age of 11.5 years and/or the presence ofan early onset of puberty in a family member [7]. The
pedigree, timing of puberty in family members and fam-
ily medical history were established at the first medical
visit.
The transmission of the phenotype was analysed
according to the pedigrees, which could include one or
more probands. First-degree relatives were defined as
mother, father, brother(s) and sister(s); second-degree
relatives as grandparents, aunt(s) and uncle(s); and
third-degree relatives as cousins. The families with at
least one first-degree relative affected were further sub-
divided into three groups: 1) unilineal families (only one
affected parent and no evidence for early puberty in the
other parent or his/her first-degree relatives); 2) bilineal
families (either both parents affected or an unaffected
parent having an affected sibling or parent); and 3) fam-
ilies with unaffected parents (one or more siblings af-
fected). Families with lineal maternal inheritance are
defined as those in which at least one member of the
mother’s family is affected with no evidence of early
puberty in the paternal side of the family, with similar
definition for lineal paternal inheritance. Uninformative
families are those where the phenotype could have been
inherited from either side of the family or where the
sex of the relatives that transmit the phenotype was
unknown.
Autosomal dominant transmission is characterized by
the presence of the phenotypes in two successive genera-
tions or more. It is characterized with incomplete pene-
trance if a generation has been skipped. Autosomal
recessive transmission included only sibs being affected
and both parents being unaffected, although this can
also be interpreted as due to de novo and dominant
mutations.
Methods
The initial clinical evaluation included determining - the
age at the onset of puberty, the height chart, the growth
rate, the weight, the pubertal stage and the BA. In all
but 8 PP cases and in 43/61 AP, the clinical examination
also included an evaluation of the hypothalamic-
pituitary-gonadal axis by measuring basal and gonado-
tropin hormone releasing hormone (GnRH) (100 μg/m2;
maximum dose 150 μg)-stimulated luteinising hormone
(LH) and follicule-stimulating hormone (FSH) peaks and
plasma concentrations of estradiol in girls and testos-
terone in boys. Pelvic ultrasound examination was per-
formed in 84 (72.5 %) of the girls to evaluate the
estrogenic stimulation of the uterus, as an aid in deter-
mining the need for GnRH analog treatment. Magnetic
resonance imaging (MRI) was performed to exclude a
hypothalamic-pituitary lesion. It was not performed in
30 patients with PP and in 38 patients with AP because
they had normal neurological evaluation, were aged
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in boys, and had low plasma estradiol (<15 pg/mL) [16]
or testosterone (<0.5 ng/mL) concentrations. The plasma
17-hydroxyprogesterone and testosterone concentrations
were measured in all boys and in the girls with pubic or
axillary hair development as the first sign of puberty.
This was performed to exclude abnormal androgen secre-
tion and congenital adrenal hyperplasia [17]. Boys also
underwent an adrenocorticotrophin hormone test. The
plasma thyroxin and thyroid-stimulating hormone con-
centrations were measured to exclude hypothyroidism,
and 24 h urinary cortisol was measured to exclude hyper-
cortisolism in those who were overweight or had a rapid
weight increase.
Age at the first evidence of puberty was reported by
the parents and subsequent studies are described in
detail elsewhere [6]. Height, growth rate and body mass
index (BMI, weight in kg/height in m squared) were
expressed as SDS for chronological age and the pubertal
stage was rated according to Marshall and Tanner
[18, 19]. BA was assessed (by R Brauner in all) using
the Greulich and Pyle method [20]. Plasma LH, FSH,
testosterone and estradiol concentrations were mea-
sured with RIA. The following values were considered
to be pubertal: uterus length ≥35 mm, LH/FSH peak
ratio after GnRH test ≥ 0.66 in girls and ≥ 2 in boys
[21], and plasma estradiol concentrations ≥ 15 pg/mL and
testosterone > 0.5 ng/mL respectively.
Results were expressed as the means ± SD. Statistical
analyses were performed using the Student test. Percent-
ages were compared by the Chi-squared test.Table 1 Characteristics of the girls with early puberty at presentatio
PP (n = 68)
n m ± SD
Age at onset, years 66 6.5 ± 1.8
Age at evaluation, years 66 7.4 ± 1.9
Height, SDS 65 2.1 ± 1.3
BMI, SDS 65 1.1 ± 1.2
BA advance, years 61 1.2 ± 1.1
Tanner breast 66 2.7 ± 0.7
Tanner pubic hair 65 2.1 ± 1.1
Age at M mothers, years 66 11.7 ± 1.5
Age at M, years 12 10.9 ± 1.8
Uterus length, mm 50 36.5 ± 9
LH peak, IU/L 63 12.2 ± 18.7
FSH peak, IU/L 63 11 ± 5.1
LH/FSH peak ratio 63 1 ± 1.1
Estradiol, pg/mL 64 11.5 ± 18
GnRH analog treatment 68 16
PP Central precocious puberty, AP Advanced puberty, M menstruationResults
We identified 154 familial cases from 139 families
with central idiopathic early puberty. This included 93
probands (68 girls and 25 boys) with PP and 61 probands
(48 girls and 13 boys) with AP (Tables 1 and 2).
Characteristics of the patients
In girls, the age at onset of puberty was < 3 years in 5
(4.3 %) patients, 3–7 years in 22 (19 %), 7–8 years in 41
(35.3 %) and 8–10 years in 48 (41.4 %). In boys, it was
7.5 years in one (2.7 %) patient, 8–10 years in 24
(63.1 %) and 10–11 years in 13 (34.2 %).
In the majority of girls, the first sign of puberty was
breast development, although in 3 girls the first sign was
pubic hair development followed by breast development
before 8 years. In the boys, the mean testicular volume
was pubertal at the initial evaluation except in 3 PP boys
and one boy with AP who presented with pubic hair
development followed by testicular enlargement before
9–10 years in PP or at 10–11 years in AP. The LH/FSH
peak ratio was pubertal in 48 girls (50 % of those evalu-
ated) and 22 boys (68.7 %).
Mode of inheritance
None of the families reported a history of consanguinity.
Familial clustering is represented in Fig. 1 and pedigrees
of the 139 families in Figs. 2 and 3.
When the families were classified according to the
degree of the transmission of their phenotype, 111
(80.4 %) had at least one affected 1st degree relative
(with grandparent affected in 15 families), 17 (12 %) hadn
AP (n = 48) Total (n = 116)
n m ± SD n m ± SD
48 8.6 ± 0.6 114 7.4 ± 1.8
47 9.4 ± 1.1 113 8.2 ± 1.9
47 1.2 ± 1.6 112 1.7 ± 1.5
47 0.7 ± 1.5 112 0.9 ± 1.4
36 0.7 ± 1.4 97 1 ± 1.2
44 2.8 ± 0.9 110 2.8 ± 0.9
42 2.4 ± 1.1 107 2.3 ± 1.1
47 11.4 ± 1.6 113 11.6 ± 1.5
12 10.7 ± 2 24 10.8 ± 1.9
34 37.2 ± 11.5 84 36.8 ± 10
33 12 ± 11.5 96 12.1 ± 16.5
33 9.8 ± 3.4 96 10.6 ± 4.6
33 1.2 ± 1 96 1.07 ± 1.1
39 12.3 ± 12.3 96 11.8 ± 16
46 6 114 22 (19,3 %)
Table 2 Characteristics of the boys with early puberty at
presentation
PP (n = 25) AP (n = 13) Total (n = 38)
n m± SD n m± SD n m± SD
Age at onset, years 25 8.8 ± 0.6 12 10.7 ± 0.5 37 9.5 ± 1.1
Age at evaluation, years 25 9.8 ± 1 13 11.4 ± 1.3 38 10.3 ± 1.3
Height, SDS 25 2.2 ± 1.6 12 0.1 ± 1.3 37 1.6 ± 1.8
BMI, SDS 24 1.2 ± 1 12 0.2 ± 1 36 0.9 ± 1.1
BA advance, years 24 1.4 ± 1.2 10 0.3 ± 1.1 34 1.1 ± 1.3
Tanner pubic hair 24 3 ± 1 11 2.8 ± 1.2 35 3 ± 1
Testicular volume, mm 21 36.4 ± 9.3 10 39.8 ± 7 31 38 ± 8.6
Age at M mothers, years 23 11.3 ± 1.5 13 11.4 ± 1.5 36 11.4 ± 1.5
LH peak, IU/L 22 14.7 ± 10.5 10 15.9 ± 5.2 32 15.1 ± 9.1
FSH peak, IU/L 22 5.4 ± 5.3 10 4.8 ± 5.6 32 5.2 ± 5.3
LH/FSH peak ratio 22 3.4 ± 2.7 10 6.1 ± 4.4 32 4.2 ± 3.5
Testosterone, ng/mL 25 1.8 ± 2.7 12 1.1 ± 1.1 37 1.6 ± 2.3
GnRH analog treatment 25 2 13 2 38 4 (10 %)
PP Central precocious puberty, AP Advanced puberty, M menstruation
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and 3rd degree relatives affected. In one family a 3rd
degree cousin was affected. In the 2 remaining families
(families 136 and 138), the unaffected mother in each
family had affected girls from two unaffected fathers.
In the 111 families with at least one affected 1st degree
relatives, at least one parent was affected in 93 families
(families 1–75, 84, 85, 102, 104, 110, 112, 115, 116, 118,
120, 121, 123–127, 129 and 131). The high prevalence of
the phenotype in parents is strongly suggestive of an
autosomal dominant mode of transmission. In 15 fam-
ilies, only sibs were affected; there was no reported fam-
ily history of PP or AP in the parents or in previous
generations (families 86–100). In these families there
was a total of 38 sibs of whom 5 were unaffected and 33
affected. It is possible that these families have an auto-
somal recessive form of the condition but it is important
to note that consanguinity was not reported in any of
these families and de novo mutations may contribute to
the phenotype.Fig. 1 Familial clustering patterns of 139 families with familial early pubertyThe crude penetrance rate was calculated by including
the data from all obligate or potential carriers. This iden-
tified 72 individuals of which 26 were reported as having
the phenotype of either PP or AP. This gives a pene-
trance value of 36 %.
Among the 93 families with at least one affected parent,
we determined if the inheritance of the phenotype was
through maternal or paternal lines. Pedigrees consistent
with exclusively maternal inheritance was observed in 75
families (families 1–75) and exclusively paternal inherit-
ance was observed in 2 families (84, 85; p < 0.0001). The
remaining 16 families were uninformative for the mode of
transmission of the phenotype.
When one includes all affected 1st, 2nd and/or 3rd
degree relatives, the mode of transmission of the pheno-
type is consistent with exclusively maternal in 83 fam-
ilies (families 1–83), paternal in 2 (families 84 and 85)
and through both male and female lineages in 15 fam-
ilies (families 101–115). The age at the onset of puberty
and clinical characteristics are not different from those
families showing unilineal and bilineal inheritances.
Other more complex modes of transmission of the
phenotype are possible for these pedigrees. For example,
imprinting anomalies may contribute to the phenotype
in families 103–106. Families 116–139 were uninfor-
mative concerning the mode of transmission of the
phenotype.
Of the 154 probands (116 girls and 38 boys) with fa-
milial early puberty, the overall female to male ratio was
3.1:1. Of the 139 families, a total of 374 cases of early
puberty were identified of whom 315 (84.2 %) were af-
fected girls and 59 (15.8 %) affected boys (Chi-squared
175.230; p < 0.0001). The overall female to male ratio
was 5.3:1. When the 125 probands, who had at least one
affected 1st degree relative (91 girls and 34 boys), and
their familial affected members (145 girls and 18 boys)
were analysed together, 236 (81.9 %) were affected girls
and 52 (18.1 %) affected boys (p < 0.001). The overall
female to male ratio was 4.5:1.
A total of 374 cases presented with early puberty, of
these 21 % of the families had exclusively PP, 25 % had
exclusively AP and 54 % had both PP and AP suggesting
Fig. 2 One hundred thirty nine families with central precocious puberty (PP) and/or advanced puberty (AP). Solid squares represent affected male
individuals and solid circles affected female individuals. The probands are indicated by an arrow in each case. Bifurcated vertical line indicates non-identical
dizygotic twins. Diamond indicates that the sex was unspecified. Pedigrees 1 to 83 are consistent with exclusively maternal inheritance. Pedigree 84
exclusively paternal inheritance
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Fig. 3 One hundred thirty nine families with central precocious puberty (PP) and/or advanced puberty (AP). Solid squares represent affected male
individuals and solid circles affected female individuals. The probands are indicated by an arrow in each case. Bifurcated vertical line indicates
non-identical dizygotic twins. Diamond indicates that the sex was unspecified. Pedigree 85 exclusively paternal inheritance, pedigrees 86 to 100
include only affected sibs, and pedigrees 101 to 115 show transmission through both male and female inheritance lineages. Pedigrees 116 to 139
are uninformative in terms of transmission
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subgroup of families showing maternal inheritance,
16.5 % exclusively PP, 31.5 % had exclusively AP and
52 % of families had both AP and PP. Although there is
a tendency towards AP with a lower incidence of PP in
the families showing maternal inheritance of the pheno-
type, this is not statistically significant.
Discussion
This is the first study examining children with preco-
cious and advanced puberty. It establishes that they both
are present in 54 % of the families studied here. In a pre-
vious study analysing 493 consecutive girls seen over
31 years for central PP (including the 68 girls with famil-
ial central PP of the present study seen over 8 years), we
found 41.4 % (192/465 after exclusion of the adopted) of
familial forms [6], while De Vries et al. reported 27.5 %
[7]. We found that the familial forms had significantly
greater frequencies of pubertal LH/FSH peak ratios and
lower plasma estradiol concentrations at the first evalu-
ation than the sporadic forms, while the ages at onset of
puberty, number of signs of puberty associated with the
breast development and frequencies of GnRH treatment
were similar. The BMI SDS was also similar in the famil-
ial and in the sporadic forms, suggesting that the familial
obesity is not the causative factor in the familial forms.
We also found a lower age at first menstruation in the
mothers of girls with familial form of CPP than in those
with sporadic forms (p = 0.0001), as reported by de Vries
et al. [7] who found similar age of the mothers in famil-
ial CPP than in our population (11.47 vs 11.5 years).
Only 5 (4.3 %) of the probands girls were aged less than
3 years at onset of puberty. All had rapidly progressing
CPP that required GnRH analog treatment [6]. Only one
boy was aged less than 8 years at onset of puberty
suggesting that pubertal onset before this age in boys
suggests organic CPP [15, 22].
In the majority of families presented here, the inherit-
ance of the phenotype is compatible with an autosomal
dominant mode of transmission with incomplete pene-
trance (36 %) and variable expressivity. We observed
three or more affected individuals in successive genera-
tions in 15 families (10.8 %), while de Vries et al. [7] re-
ported that in 47.8 % of the central PP cases three
generations were affected. The lower frequency reported
here is probably due to the fact that de Vries et al. in-
cluded only families in whom the age at puberty in threegenerations was known. Similar to previous studies we
found a higher incidence of girls compared to boys when
all the affected members are included (5.3:1). The strik-
ing observation in this study is the degree to which in-
heritance of PP or AP is transmitted through the
maternal lineage. Of the 93 pedigrees with at least one
parent affected, 80.6 % had an exclusively maternal in-
heritance of the phenotype with only two families having
exclusively paternal inheritance. When we include all
pedigrees, with the exception of the families with only
affected sibs (n = 15) the values are 66.9 % of families
consistent with exclusively maternal inheritance, 1 %
exclusively paternal and 12.1 % inherited through both
male and female lineages and 19.4 % uninformative. De
Vries et al. also found no consanguinity in their 46 fam-
ilies [7]. Recently, Wohlfahrt-Veje et al. [23] by evaluat-
ing a longitudinal cohort found that both maternal and
paternal timing of puberty had a strong influence on the
timing of pubertal onset in children, and this was not
sex-specific.
Alterations in genomic imprinting may play a key role
in anomalies of pubertal timing. Recently, in a study of
15 families with central PP, 5 families were identified
who carried heterozygous frameshift or missense muta-
tions in the MKRN3 gene that encodes the makorin
RING-finger protein 3 [24]. The precise function of
MKRN3 is unclear but may be involved in ubiquitin-
ligase activity. The Mkrn3 gene is expressed in the arcu-
ate nucleus of both male and female mice at postnatal
day 10 and declined thereafter [25]. The arcuate nucleus
expresses a number of key genes involved in pubertal
development such as Kisspeptin and TAC2, whose ex-
pression increases as the levels of Mkrn3 decline. Thus,
MKRN3 would act as a negative regulator of puberty,
with loss-of-function mutations resulting in central PP.
Interestingly, MKRN3 is subject to imprinting and it is
expressed exclusively from the paternally inherited chro-
mosome [24]. In total 26 mutations have been described
in the MKRN3 gene, of which 10 are frameshift muta-
tion, 13 missense mutations and 3 nonsense mutations
[26–28]. Where it was possible to study all of the af-
fected persons inherited the mutation from their fathers.
Here, we observed a predominant maternal inheritance
of PP/AP rather than paternal inheritance. This could
either be due to the high incidence of early puberty
in girls (and hence higher frequency of maternal
transmission) or the phenotype may be influenced by
Durand et al. BMC Endocrine Disorders  (2016) 16:50 Page 8 of 8transmission of mutations involving a maternally imprinted
gene. This could be resolved by the analysis of large and
informative familial cases of PP/AP.
Conclusions
The data confirm the high incidence of affected girls with
early puberty compared with boys in familial cases. The
mode of inheritance of the phenotype is predominantly
maternal. More than half of the families included both pre-
cocious and advanced puberty suggesting similar factors.
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